Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation

• Yoko Nishinaka-Arai,
• Akira Niwa,
• Shiori Matsuo,
• Yasuhiro Kazuki,
• Yuwna Yakura,
• Takehiko Hiroma,
• Tsutomu Toki,
• Tetsushi Sakuma,
• Takashi Yamamoto,
• Etsuro Ito,
• Mitsuo Oshimura,
• Tatsutoshi Nakahata,
• Megumu K. Saito

Affiliations

Yoko Nishinaka-Arai

Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;

Akira Niwa

Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;

Shiori Matsuo

Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;

Yasuhiro Kazuki

Chromosome Engineering Research Center, Tottori University, Tottori, Japan;

Yuwna Yakura

Chromosome Engineering Research Center, Tottori University, Tottori, Japan;

Takehiko Hiroma

Perinatal Medical Center, Nagano Children's Hospital, Nagano, Japan;

Tsutomu Toki

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;

Tetsushi Sakuma

Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;

Takashi Yamamoto

Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;

Etsuro Ito

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;

Mitsuo Oshimura

Chromosome Engineering Research Center, Tottori University, Tottori, Japan;

Tatsutoshi Nakahata

Center for iPS cell Research and Application, Kyoto University, Kyoto, Japan

Megumu K. Saito

Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;